Lifecore Biomedical discloses DOJ, SEC investigation into potential FCPA matters at Mexico facility
MLex Summary: Pharmaceutical company Lifecore Biomedical has disclosed information to the US Department of Justice and the Securities and Exchange Commission regarding "potential compliance matters" concerns related to the Foreign Corrupt...To view the full article, register now.
Already a subscriber? Click here to view full article